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A trio of studies in this issue of Cell Stem Cell from Mirzadeh et al., Shen et al., and Tavazoie et al. use three-
dimensional imaging techniques to reveal microanatomical details of the adult neural stem cell niche.
Combined, the results also provide a framework for future functional studies.Adult NSCs arise from radial glia within
the subventricular zone (SVZ) of the lateral
ventricles (Merkle et al., 2004), one of two
regional concentrations of NSCs in the
brain that include the dentate gyrus sub-
granular zone (Alvarez-Buylla and Lim,
2004). Although the potency of NSCs ren-
ders them an attractive resource in the
hunt for cures of neurodegenerative dis-
eases, the mechanisms that control the
behavior of these cells remain largely
unknown.
Similar to other tissue-specific stem
cells, NSCs are presumed to exist in
specializedmicroenvironments, or niches,
that regulate their function. Thus, a better
understanding of the architecture of the
ependymal layer and SVZ could yield
important insights into the mechanisms
that regulate NSCs; however, a clear
view of the complex three-dimensional
arrangement of blood vessels, cell pro-
cesses, and extracellular matrix (ECM)
proteins found in this region of the brain
is lost among the thin tissue sections
processed using conventional histologic
approaches. Therefore, three studies in
this issue have used novel whole-mount
imaging techniques to provide the first234 Cell Stem Cell 3, September 11, 2008 ª2high-resolution, three-dimensional de-
scriptions of the adult NSC niche.
Tavazoie et al. (2008) and Shen et al.
(2008) focused their studies on the cellular
and molecular interactions surrounding
the SVZ vasculature, since emerging evi-
dence has suggested that blood vessels
are key components of tissue-specific
stem cell niches (Palmer et al., 2000;
Shen et al., 2004; Yoshida et al., 2007).
Using glial fibrillary acidic protein-green
fluorescence protein (GFAP-GFP) trans-
genic reporter mice, they demonstrate
that the SVZ vasculature includes an ex-
tensive, superficial network of planar in-
terconnected blood vessels that spans
the entire SVZ, just beneath the ependy-
mal layer. Their studies demonstrate that
GFAP+/LeX+ BrDU-retaining NSCs inter-
act closely with these vessels, an intimate
relationship that Shen and colleagues
report Type A neuroblasts retain as they
migrate from theSVZ to the olfactory bulb.
A noteworthy insight provided by these
studies and those of Mirzadeh et al.
(2008) is the demonstration that adult
NSCs, similar to their radial glial fore-
bears, are highly polarized, contacting
the ventricle through a short apical pro-008 Elsevier Inc.cess and a blood vessel through a long
basal process. Indeed, Mirzadeh et al.
(2008) show that these basal processes
contribute to the gliotubes that seem to
guide migrating neuroblasts, much as ra-
dial glial fibers guide neuroblasts up to the
developing cortical plate. Although adult
NSCs have been shown to arise from ra-
dial glia (Merkle et al., 2004), and neuro-
genic radial glia have been identified in
the adult songbird brain, the data con-
tained in this issue of Cell Stem Cell sug-
gest that mammalian radial glia progeni-
tors establish critical structure-function
relationships within the niche that are
inherited by adult NSCs.
A close interaction between SVZ NSCs
and blood vessels might be expected in
light of similar cell-cell interactions in the
hippocampus (Palmer et al., 2000); how-
ever, data from Tavazoie et al. provide
the first evidence that these sites of
neurovascular interaction have functional
significance in vivo. They show that
NSC-vessel contacts in the SVZ are un-
usually permeable and frequently devoid
of astrocytic endfeet or a pericyte sheath
(features of the blood-brain barrier that
minimize access of neural cells to
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Previewscirculating molecules through-
out the rest of the brain). Prior
studies have shown that
NSCs are regulated by endo-
thelial-derived factors (Shen
et al., 2004); thus, the new ul-
trastructural data from Tava-
zoie et al. (2008) might reveal
how NSCs gain access to
these factors. The potential
significance of these neuro-
vascular interactions is sup-
ported further by evidence
that these locations can act
as staging posts for regenera-
tion of the SVZ niche following
chemical ablation of transient
amplifying cells and neuro-
blasts (Tavazoie et al., 2008).
In addition to the vascula-
ture, ECM proteins are be-
lieved to provide both a physi-
cal framework and instructive
signals within stem cell niches.
With this in mind, Shen and
colleagues looked in the SVZ
to see if NSCs express the
laminin receptor a6b1 integrin
(VLA6), since laminin was
found to be abundant and
localized around blood ves-
sels. They observed VLA6 ex-
pression in vessel-associated
cells as well as neurosphere
cultures of LeX+ cells, and that preincuba-
tion of SVZ neurospheres with an integrin
neutralizing antibody inhibited the binding
of NSCs to endothelial cells in culture.
Further, infusion of an integrin neutraliz-
ing antibody directly into the lateral ven-
tricle of adult mice released SVZ cells
from the vasculature and increased cell
proliferation. Integrin-laminin interactions
have been reported to act as stem cell
‘‘anchors’’ in other organisms, including
invertebrates (Tanentzapf et al., 2007);
thus, the data from Shen and colleagues
extend the concept that these proteins
are critical regulators in niche microenvi-
ronments.
Complementing these studies, Mirza-
deh et al., provide an exquisite picture
of the cellular architecture within the
ependymal layer and SVZ of the lateral
ventricle. The positioning and identity of
NSCs relative to the ependymal layer
have been the subject of much contro-
versy. Some studies suggest that adult
NSCs are located within the SVZ and
only rarely contact the ventricle through
an apical process (Doetsch et al., 1999),
while others suggest that the ependymal
cells are capable of re-entering the cell
cycle as multipotent progenitors in re-
sponse to injury (Coskun et al., 2008).
To peak beneath the carpet of cilia that
obscures the ventricle wall, Mirzadeh
et al. used g-tubulin and b-catenin anti-
bodies to label the basal bodies and
cell membranes, respectively, of cells in
the ependymal layer. In doing so, they
identified two different non-NSC cell
types that contact the adult lateral ventri-
cle: ependymal cells with multiple basal
bodies and multiple long cilia (termed
E1 cells) and a previously unknown cell
(termed E2) with complex basal bodies
and two long cilia. These two cell types
were located within all regions of the
ventricle and showed no evidence of
proliferation. The discovery of E2 cells
is particularly noteworthy. The relative in-
frequency of these biciliated cells sug-
gests that they are unlikely to contribute
much to maintaining CSF
flow; however, recent evi-
dence that cilia can coordinate
cell signaling raises the excit-
ing possibility that E2 cells
function as transducers of cell
signals between the ventricle
and the SVZ. In contrast to
E1 and E2 cells, the third cell
type observed in this location,
Nestin+/CD24 NSCs, were
often Prominin1+ and remark-
ably numerous (over 6200 in
the lateral wall of the lateral
ventricle of one mouse). These
NSCs were restricted to the
lateral and anterior medial
walls of the lateral ventricle,
coinciding with the neurogenic
niche. Within these neurogenic
‘‘hotspots’’ NSCs are shown to
be arranged in a striking ‘‘pin-
wheel’’ formation, in which
the apical surface of one or
more NSCs is surrounded by
packed E1 cells (Figure 1). Im-
portantly, it is highly likely that
the CD133+/CD24 NSCs with
apical processes are the stem
cells misidentified in other
studies as ependymal cells
with stem cell properties (Cos-
kun et al., 2008).
Together, the data provided
in the three articles in this issue im-
prove our understanding of NSC niche
architecture and establish a vital founda-
tion for future functional studies that may
ultimately uncover the mechanisms that
underlie NSC regulation in vivo.
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Figure 1. Depicting Neural Stem Cells in Their Niche
Cartoon illustrating the remarkable ‘‘pinwheel’’ arrangement of neural stem
cells (blue) and ependymal type 1 (E1) and E2 cells in the wall of the lateral
ventricle in work revealed by Mirzadeh et al. (2008). Artwork by Kenneth
Xavier Probst.Cell Stem Cell 3, September 11, 2008 ª2008 Elsevier Inc. 235
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Two recent studies report the generation of induced pluripotent stem cells from patients presenting with a
total of elevendifferentdiseases (Parket al., 2008;Dimoset al., 2008). Futuredifferentiationstudiesusing these
lines may offer insight on specific disease pathophysiology and aid the design of protective drug therapies.
The advent of human embryonic stem cell
(hESC) technology has fostered great
optimism that if their extensive, though
unpredictable, in vitro differentiation
properties could be harnessed appropri-
ately, these pluripotent cells could
provide powerful models of human devel-
opment and disease, as well as material
for cell replacement therapies. Although
this vision has been partially delivered
with the provision of disease-specific
hESC lines from afflicted embryos identi-
fied in preimplantation diagnostic screen-
ing programs (Pickering et al., 2005), only
common, monogenic conditions can be
captured in this way. Somatic cell nuclear
transfer using adult cell donors offers
a more comprehensive route to patient-
specific hESC. However technical, logisti-
cal, and ethical difficulties have, to date,
presented insuperable difficulties. The
landmark discovery by Takahashi and Ya-
manaka (reviewed in Yamanaka, 2007)
that induced pluripotent stem cells
(iPSCs), which share very similar proper-
ties with hESCs, could be prepared from
mouse skin fibroblasts, has already been
reproduced for a variety of human cell
types taken from healthy donors. In the
last month, two papers have been pub-
lished describing the generation of iPSC
lines from individual patients harboring
a variety of both simple and complex
genetic diseases.
Daley and colleagues (Park et al., 2008)
report the production of human iPSC lines
for tendiseases, ranging fromsimpleMen-
delian traits, likeadenosinedeaminasede-
ficiency and Gaucher disease type III, to
complex conditions, like Parkinson’s dis-
ease and Type 1 diabetes. In addition,
they generated a line from a female carrier
of Lesch-Nyhan syndromewith its charac-
teristicmutation in one of the two alleles of
the X-linked hypoxanthine-guanine phos-
phoribosyltransferase (hprt) gene. By
analogy to the classic work using mouse
hprt+/ ESCs, these human cells should
proveextremely valuable in refining strate-
gies for studies of homologous recom-
bination as well as X chromosome acti-
vation/inactivation. These various lines
were made by the now standard proce-
dure of infecting dermal fibroblasts or, in
one case, bone marrow mesenchymal
cells, with disabled retroviruses express-
ing the reprogramming factors OCT4,
SOX2, KLF4, and c-MYC. The resulting
iPSC lines displayed a variety of pluripo-
tent stem cell markers (including NANOG,
SSEA-3, and -4), and all of those tested
could differentiate in vitro (embryoid bod-
ies) and in vivo (teratoma formation in
immunodeficient murine hosts) into cell
lineages characteristic of all three embry-
onic germ layers (ectoderm, mesoderm,
and endoderm).
Eggan and colleagues (Dimos et al.,
2008) used similar methods to produce
iPSC lines from skin cells from an 82-
year-old female patient diagnosed with
a familial form of amylotrophic lateral scle-
rosis (ALS; also known as Lou Gehrig’s
disease). This lesion, which in this case
was caused by a mutation in the superox-
ide dismutase gene, leads to motor neu-
ron loss in the spinal cord and motor
cortex with resulting paralysis and death.
By converting the iPSCs into motor neu-
rons and glial cell types, they established
that reprogramming and in vitro differenti-
ation are not necessarily thwarted by do-
nor age. This is an important benefit given
thatmanygeneticdiseasesareof sporadic
occurrence, with no family history, andbe-
come only evident with advancing years.
Park et al. conclude their paper by sig-
naling their intent to provide these lines
as a resource to the biomedical research
community. This is an eminently laudable
declaration, and one hopes that the in-
ventory of disease-specific lines will be
expanded rapidly in the near future. How-
ever, before the full potential of these iPSC
lines can be realized, a number of uncom-
fortable issues have to be addressed.
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